Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

MLA

White HD, et al. “Safety and Efficacy of Bivalirudin with and without Glycoprotein IIb/IIIa Inhibitors in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention 1-Year Results from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) Trial.” Journal of the American College of Cardiology (JACC), vol. 52, no. 10, Sept. 2008, pp. 807–14. EBSCOhost, https://doi.org/10.1016/j.jacc.2008.05.036.

APA

White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, Cox DA, Pocock SJ, Ware JA, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Stone GW, White, H. D., Ohman, E. M., Lincoff, A. M., Bertrand, M. E., Colombo, A., & McLaurin, B. T. (2008). Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. Journal of the American College of Cardiology (JACC), 52(10), 807–814. https://doi.org/10.1016/j.jacc.2008.05.036

Chicago

White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, Cox DA, et al. 2008. “Safety and Efficacy of Bivalirudin with and without Glycoprotein IIb/IIIa Inhibitors in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention 1-Year Results from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) Trial.” Journal of the American College of Cardiology (JACC) 52 (10): 807–14. doi:10.1016/j.jacc.2008.05.036.